Cardiology (all articles)
Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic
17 Jan, 2021 | 22:01h | UTCRemote monitoring in heart failure: current and emerging technologies in the context of the pandemic – Heart (free for a limited period)
Cardiovascular complications of opioid use: JACC state-of-the-art review
17 Jan, 2021 | 22:04h | UTC
Study: Vaping combined with smoking may be as harmful as smoking cigarettes alone
17 Jan, 2021 | 21:53h | UTCCommentaries: Vaping combined with smoking is likely as harmful as smoking cigarettes alone, study finds – American Heart Association AND CVD Biomarker Levels Up for Dual Use of E-Cigarettes, Cigarettes – Physician’s Weekly
Consensus statement: Diagnosis, treatment, and follow-up of heart failure patients by general practitioners
17 Jan, 2021 | 21:48h | UTC
Systematic review: Insufficient evidence to recommend Trypanocidal drugs for late-stage, symptomatic Chagas disease
17 Jan, 2021 | 21:44h | UTCSummary: Trypanocidal drugs for late-stage, symptomatic Chagas disease – Cochrane Library
Review: Anesthetic management of conduction disturbances following transcatheter aortic valve replacement
17 Jan, 2021 | 21:39h | UTC
Commentary on Twitter
Conduction disturbances remain common following transcatheter aortic valve replacement (#TAVR). Anesthetic Management of Conduction Disturbances following Transcatheter Aortic Valve Replacement: A Review of the 2020 ACC Expert Consensus Decision Pathway. https://t.co/s7e2MEJFAI pic.twitter.com/VqUcdUEehp
— Journal of Cardiothoracic and Vascular Anesthesia (@JCVAonline) December 26, 2020
Meta-analysis of randomized trials: SGLT-2 inhibitors and GLP-1 receptor agonists reduce cardiovascular and renal outcomes in type 2 diabetes
15 Jan, 2021 | 08:41h | UTCCalculator based on the results: interactive decision support tool for outcomes
Cohort study: Even small amounts of alcohol consumption linked to increased risk of atrial fibrillation
15 Jan, 2021 | 08:40h | UTCEditorial: Alcohol consumption, atrial fibrillation, and cardiovascular disease: finding the right balance
Study: Despite recommendations, less than 2 percent of patients with treatment-resistant hypertension were tested for primary aldosteronism in a large U.S. cohort
14 Jan, 2021 | 01:55h | UTCTesting for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans: A Retrospective Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries: Primary Aldosteronism Testing Rare in Treatment-Resistant HTN – HealthDay AND Primary Aldosteronism Testing Rare for Patients with Resistant Hypertension – NEJM Journal Watch
Commentary from the author on Twitter (thread – click for more)
Our new study is out in @AnnalsofIM w/@BhallaResearch @thebyrdlab @johnleppert! 👇https://t.co/UCrAD4ed0w
We asked: Are patients w/treatment resistant HTN being appropriately tested for primary aldosteronism (PA) & managed w/mineralocorticoid receptor antagonists (MRAs)? 1/ pic.twitter.com/jO4cqA37sD
— Jordy Cohen, MD, MSCE (@jordy_bc) December 28, 2020
2021 ACC Expert consensus decision pathway for optimization of heart failure treatment
13 Jan, 2021 | 02:01h | UTCCommentary: ACC Issues Updated Guidance For Managing Patients With HFrEF – American College of Cardiology
2021 ACC Expert Consensus: Same-day discharge after percutaneous coronary intervention
13 Jan, 2021 | 02:05h | UTCCommentaries: 2021 ACC Expert Decision Pathway on Same-Day Discharge After PCI – American College of Cardiology AND Checklist for Same-Day Discharge PCI Stresses Buy-In, and a Plan – TCTMD AND Same-Day Discharge After PCI: ACC Expert Consensus Decision Pathway – Cardiology Advisor AND Ticking all the right boxes for same-day discharge PCI – MDedge Cardiology
Case series: Safety of same‐day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID‐19 era
13 Jan, 2021 | 02:03h | UTCCommentary: Pandemic Prompts Closer Look at Same-Day Discharge After TAVI – TCTMD
Commentary on Twitter
With dwindling hospital capacity from #COVID19, study of safety of same‐day discharge after #TAVR @emoryhealthcare available via @CCIJournal. SDD after uncomplicated #TAVR in selected patients may open beds & prevent unnecessary CV morbidity. https://t.co/fuTdVUrFu5
— Chandan Devireddy (@drdevireddy) December 31, 2020
HEAR or HEART Pathway – Can We Drop Troponin?
13 Jan, 2021 | 01:59h | UTCHEAR or HEART Pathway – Can We Drop Troponin? – Journal Feed
Original Study: Identification of very low-risk acute chest pain patients without troponin testing – Emergency Medicine Journal
Randomized trial: Renin–angiotensin system inhibitors can be safely continued in patients admitted to hospital with COVID-19
12 Jan, 2021 | 01:59h | UTC
NEW Research—renin–angiotensin system inhibitors can be safely continued in patients admitted to hospital with #COVID19
RCT from Julio Chirinos & colleagues https://t.co/ZNfqJ0NsRK pic.twitter.com/Kpg6xSsWKl
— The Lancet Respiratory Medicine (@LancetRespirMed) January 8, 2021
Atrial fibrillation and stroke prevention: state of the art—epidemiology and pathophysiology: New risk factors, concepts and controversies
12 Jan, 2021 | 01:47h | UTC
ACC Consensus: Anticoagulation and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing PCI or with atherosclerotic cardiovascular disease
12 Jan, 2021 | 01:50h | UTCCommentaries: ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE – TCTMD AND ACC Issues Clinical Guidance For Antithrombotic Therapy in Patients With AFib or VTE Undergoing PCI or With ASCVD – American College of Cardiology
Commentary on Twitter
ICYMI: @ACCinTouch released clinical guidance for antithrombotic therapy in pts w/ #AFib/#VTE undergoing PCI or w/ #ASCVD. Doc aims to serve as a framework for decision-making among pts requiring concomitant use of an anticoagulant & antiplatelet therapy. https://t.co/PqinRIvLY9 pic.twitter.com/prbnbBPG5L
— JACC Journals (@JACCJournals) December 29, 2020
Another study suggests fluoroquinolone use may increase the risk of development of aortic aneurysms
12 Jan, 2021 | 01:38h | UTCAssociation of Fluoroquinolone Use With Short-term Risk of Development of Aortic Aneurysm – JAMA Surgery (free for a limited period)
Commentaries: Fluoroquinolones and Aortic Disease—Is It Time to Broaden the Warning? – JAMA (free for a limited period) AND Study links fluoroquinolones to higher risk of aneurysm – CIDRAP AND Analysis Links Fluoroquinolones to Increased Aortic Aneurysm Risk – Physician’s Weekly
Systematic Review: “For the general population of persons with elevated blood pressure, the benefits of trying to achieve a lower blood pressure target rather than a standard target (140/90 mm Hg or less) do not outweigh the harms associated with that intervention.”
12 Jan, 2021 | 01:30h | UTCBlood pressure targets in adults with hypertension – Cochrane Library
Summary: The use of lower blood pressure targets for people with hypertension – Cochrane Library
Related systematic review: Blood pressure targets in people with cardiovascular disease – Cochrane Library
Commentary on Twitter
The use of lower #bloodpressure targets for people with #hypertension https://t.co/W1bF8W7CDD Updated @CochraneHTN systematic review includes 11 randomised controlled trials involving 38,688 adult participants.
— Cochrane (@cochranecollab) December 30, 2020
[Abstract Only] Randomized trial: No difference in long-term outcomes with endovascular revascularization plus supervised exercise vs. supervised exercise only for intermittent claudication
12 Jan, 2021 | 01:15h | UTCLong-Term Follow-up of a Randomized Clinical Trial Comparing Endovascular Revascularization Plus Supervised Exercise with Supervised Exercise only for Intermittent Claudication – Annals of Surgery (link to abstract – $ for full-text)
Randomized trial: Low-dose digoxin results in similar patient-reported quality of life compared to bisoprolol for heart rate control in atrial fibrillation
10 Jan, 2021 | 20:37h | UTCEffect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
Editorial: Digitalis Glycosides for Heart Rate Control in Atrial Fibrillation
Commentary: Digoxin Could Sub for Beta-Blockers in Certain Afib Patients – Physician’s Weekly
Commentary on Twitter
In this RCT, low-dose #digoxin led to no difference in patient-reported quality of life at 6 months vs bisoprolol in patients with permanent atrial fibrillation and symptoms of heart failure. @ICVS_UoB #afib https://t.co/XtCPdba5xg
— JAMA (@JAMA_current) December 28, 2020
Observational study: Childhood growth hormone treatment linked to increased risks of cardiovascular events in early adulthood
10 Jan, 2021 | 20:27h | UTCAssociation of Childhood Growth Hormone Treatment With Long-term Cardiovascular Morbidity – JAMA Pediatrics (link to abstract – $ for full-text)
Commentaries: Childhood Tx with Growth Hormone May Up Cardiovascular Risks Later – Physician’s Weekly AND Growth Hormones in Childhood Tied to Heart Problems Later On – MedPage Today (free registration required)
Guideline Synopsis: Management of patients with a patent foramen ovale with history of stroke or TIA
10 Jan, 2021 | 20:19h | UTCManagement of Patients With a Patent Foramen Ovale With History of Stroke or TIA – JAMA (free for a limited period)
Original Guideline: Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology – Neurology
Study suggests that 7 days of home blood pressure monitoring is likely better than 24h ambulatory monitoring or 3 office measurements
10 Jan, 2021 | 20:17h | UTCEditorial: Which Blood Pressure Measurement Best Predicts Cardiovascular Outcomes?
Commentary: Is Home BP Monitoring the Best Approach For Diagnosing HTN? – American College of Cardiology
Effects of low sodium diet vs. high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride
10 Jan, 2021 | 20:12h | UTC
2020 ACC/AHA Guideline for the management of patients with valvular heart disease
18 Dec, 2020 | 09:45h | UTCNews release: Updated guideline for heart valve disease spotlights less invasive treatments
Key Perspectives: Part 1
Key Perspectives: Part 2
Key Perspectives: Part 3
Commentary on Twitter
New ACC/@American_Heart Guideline for the Management of patients with #cvVHD includes expanded treatment options; recommends less invasive interventions, when possible; and stresses the importance of #SharedDecisionMaking. Read it in #JACC: https://t.co/g9RE9buXNC pic.twitter.com/jnwt8d5QC7
— JACC Journals (@JACCJournals) December 17, 2020


